1. Home
  2. DRMA vs DFLI Comparison

DRMA vs DFLI Comparison

Compare DRMA & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRMA
  • DFLI
  • Stock Information
  • Founded
  • DRMA 2014
  • DFLI 2020
  • Country
  • DRMA United States
  • DFLI United States
  • Employees
  • DRMA N/A
  • DFLI N/A
  • Industry
  • DRMA Biotechnology: Pharmaceutical Preparations
  • DFLI Electronic Components
  • Sector
  • DRMA Health Care
  • DFLI Technology
  • Exchange
  • DRMA Nasdaq
  • DFLI Nasdaq
  • Market Cap
  • DRMA 4.5M
  • DFLI 5.0M
  • IPO Year
  • DRMA 2021
  • DFLI N/A
  • Fundamental
  • Price
  • DRMA $0.75
  • DFLI $0.50
  • Analyst Decision
  • DRMA Strong Buy
  • DFLI Strong Buy
  • Analyst Count
  • DRMA 1
  • DFLI 4
  • Target Price
  • DRMA $6.00
  • DFLI $12.83
  • AVG Volume (30 Days)
  • DRMA 4.2M
  • DFLI 252.3K
  • Earning Date
  • DRMA 05-14-2025
  • DFLI 05-13-2025
  • Dividend Yield
  • DRMA N/A
  • DFLI N/A
  • EPS Growth
  • DRMA N/A
  • DFLI N/A
  • EPS
  • DRMA N/A
  • DFLI N/A
  • Revenue
  • DRMA N/A
  • DFLI $50,645,000.00
  • Revenue This Year
  • DRMA N/A
  • DFLI $42.48
  • Revenue Next Year
  • DRMA N/A
  • DFLI $42.95
  • P/E Ratio
  • DRMA N/A
  • DFLI N/A
  • Revenue Growth
  • DRMA N/A
  • DFLI N/A
  • 52 Week Low
  • DRMA $0.69
  • DFLI $0.56
  • 52 Week High
  • DRMA $6.17
  • DFLI $13.14
  • Technical
  • Relative Strength Index (RSI)
  • DRMA 34.82
  • DFLI 18.84
  • Support Level
  • DRMA $0.69
  • DFLI $0.60
  • Resistance Level
  • DRMA $0.85
  • DFLI $0.67
  • Average True Range (ATR)
  • DRMA 0.08
  • DFLI 0.09
  • MACD
  • DRMA -0.00
  • DFLI 0.02
  • Stochastic Oscillator
  • DRMA 21.43
  • DFLI 7.39

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc. is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

About DFLI Dragonfly Energy Holdings Corp. (NV)

Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a highly cost-effective storage solution.

Share on Social Networks: